Anabolic Steroids/Hormones
Anadrol
Also called Oxymetholone · A50 · Drol
Anadrol is sought for rapid size, fullness and strength, and is often compared with Dianabol. The practical catch is that some users report feeling tired or losing their appetite while trying to gain weight. A fast scale increase is not all new muscle, and the liver, cholesterol and fluid-retention risks still matter.
Dosage & duration
One published nonmedical guide · oral oxymetholone
Reported bodybuilding use
Reported use · unapproved regimen- Dose
- 50–150 mg total per day
- How often
- Divided across the day in this guide
- How long
- Up to 6 weeks in this guide
Descriptive source example, not a safe dose or cycle. Higher amounts and stacking advice are not endorsed.
Sources: 1
Anadrol at a glance
Rapid fullness is not all new muscle
-
Size and strength
People seek a full muscular look and rapid progress in the gym.
-
Fluid affects weight
Fluid retention can add to a fast scale increase and may fall after stopping.
-
Appearance misses harm
Feeling strong does not reveal liver injury or adverse cholesterol changes.
Why do users compare Anadrol with Dianabol?
Both feature in discussions about rapid size and strength. Anadrol reports often emphasize fullness, pumps and substantial scale movement. Those observations do not distinguish lasting muscle from fluid, especially when other drugs and diet changes are involved.
Why can a “bulking” drug make eating harder?
Some people report impressive fullness alongside tiredness, poor appetite or stomach trouble. Others report little appetite change, and not everyone notices the same strength benefit. That explains why enthusiastic reviews and disappointing ones coexist. The accounts do not establish the cause of a symptom or a way to prevent it.
Dose and duration in context
The visible figures describe one reported bodybuilding example. They are not a medical regimen. The product’s medical history concerns certain anemias, where treatment goals and monitoring differ substantially from bodybuilding.
What can go wrong?
The archived label describes liver injury, adverse blood-fat changes and edema. It also includes hormone and reproductive effects. A reputation for rapid gains should not obscure swelling, shortness of breath or jaundice; these need clinical assessment rather than adding another drug to counter symptoms.
What the curve helps with
It illustrates timing from the retained model. It cannot forecast how much weight stays after stopping, estimate liver strain or validate a stack.
Model details: Anadrol · relative timing
Compare timing and buildup for this compound. The values are not blood concentrations or a measure of strength.
Shows a relative timing scenario; absolute blood concentrations are not calibrated.
Timing assumptions and sources
Tmax source 210 min÷60; 8 h is declared assumed terminal shape, not reverified primary parameter.
One 1 mg input peaks at 1 relative unit after a single dose. Other amounts scale proportionally; overlapping doses add when accumulation is on. Different compounds use separate relative scales.
- Timing half-life used
- 8 hours
- Absorption half-life assumed
- 1.031691 hours
- Reference amount for the relative scale
- 1 mg
- The faster rate is inferred to match the 3.5 h source-scoped peak time; absorption half-life 1.0316907771179677 h is a mathematical shape parameter, not separately measured.
- A single 1-unit input has a peak of 1 relative unit; scaling and repeated-dose addition are mathematical assumptions. This normalization is independent of the example dose.
- Half-life 8 h retained as an explicit shape estimate; original abstract verifies peak/time but not terminal half or cohort count. Full article access was limited.
- Food state/formulation details and linear accumulation are not fully established.
- No extra 0.95 F multiplier; observed oral endpoint already contains absorption.
- Cardoso 2002 oxymetholone human plasma assay/PK
50 mg oral healthy-volunteer dose gave 18.8 ng/mL peak at 210 min; extraction recovery is not oral F.
anadrol-relative-timing-2026-10 · version 1
Safety and interaction notes Read the limitations and discuss clinical questions with a professional
- Aromatizes
- No
- DHT derivative
- Yes
Common questions
Does Anadrol weight gain equal new muscle?
No. Fluid and other body-composition changes can contribute, so a scale reading is not a muscle measurement.
Does no estrogen conversion mean no swelling?
No. The product label warns about edema; a mechanism claim does not rule it out.
Does Anadrol always improve workout energy and appetite?
No. Those are not reliable expectations: some report feeling stronger yet tired or less interested in food, while others do not. The medical label separately lists nausea, vomiting and diarrhea. A change in how you feel does not identify the cause or show whether liver tests are normal.
Sources Labels, studies and notes behind this guide
Catalog evidence: Other human research. This describes the type of evidence, not a clinical review of every claim.
Summary and fact source checks: 2026-10-10, 2026-10-07. This records source checking, not medical review of the whole page.
Notes on the quick facts
- Why people seek it
- These are common goals in Anadrol discussions; individual results are unpredictable.
- Scale weight
- Fluid retention can contribute to the change and may fall after stopping.
- Main trade-off
- Feeling strong does not tell you whether the drug is causing harm.
- 1. FDA — archived Anadrol-50 label
Archived oxymetholone label: anemia indication, serious liver disease, lipid changes, edema and androgenic/reproductive warnings.
- 2. Cardoso 2002 oxymetholone human plasma assay/PK
50 mg oral healthy-volunteer dose gave 18.8 ng/mL peak at 210 min; extraction recovery is not oral F.
- 3. Anadrol-50 — DailyMed product information
Label text checked directly. Oxymetholone for deficient-red-cell-production anemias; liver, lipid, edema and androgen warnings. Historical label is not proof of current local availability.
- 4. Cardoso et al. 2002 — oxymetholone plasma assay and human PK
Abstract checked. Oral 50 mg in healthy volunteers; mean peak 18.8 ng/mL around 210 minutes. Assay extraction recovery is not oral bioavailability.
- 5. ChEBI — oxymetholone chemical identity (CHEBI:7864)
Authoritative chemical definition checked: a substituted 4,5α-dihydrotestosterone structure. Supports DHT-derived classification; not a clinical safety or estrogen-symptom guarantee.
- 6. Schroeder et al. 2003 — oral oxymetholone study
Primary clinical paper; its indexed journal discussion identifies oxymetholone as nonaromatizable. Full journal opening was access-limited; PubMed abstract verifies study identity/design. This is classification support, not a direct aromatase assay or an explanation for gynecomastia.
Keep reading
Related compounds and examples
Related compounds
Halotestin
Halotestin, or Halo, comes up around powerlifting strength, intense training drive and a harder-looking contest physique rather than large weight gain. Some users like the focus; others describe anger and an experience they would not repeat. Serious liver and other health risks remain even when a workout feels better.
Dianabol
Dianabol attracts lifters who want fast strength gains and a fuller, bigger look. Users also describe a feel-good effect, but bloating and painful back pumps can spoil the appeal. Rapid scale gain is not all lasting muscle; blood-pressure and liver risks matter even when training feels great.
Turinabol
Turinabol attracts lifters who want better gym stamina, strength and a fuller look without the big water-weight swing they associate with Dianabol. Reports are mixed: some feel more athletic, while others find headaches, shin pumps or stomach trouble outweigh the benefit. Its mild reputation is not a safety guarantee.